No discrepancy between in vivo gene marking efficiency assessed in peripheral blood populations compared with bone marrow progenitors or CD34+ cells.
第一作者:
S E,Sellers
第一单位:
Hematology Branch, NHLBI, NIH, Bethesda, MD 20892, USA.
作者:
主题词
动物(Animals);抗原, CD34(Antigens, CD34);碱基序列(Base Sequence);血细胞(Blood Cells);DNA引物(DNA Primers);抗药性(Drug Resistance);基因转移技术(Gene Transfer Techniques);遗传标记(Genetic Markers);造血干细胞(Hematopoietic Stem Cells);人类(Humans);猕猴(Macaca mulatta);新霉素(Neomycin);转导, 遗传(Transduction, Genetic)
DOI
10.1089/10430349950018706
PMID
10094206
发布时间
2018-12-01
- 浏览2

Human gene therapy
633-40页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文